Teva Pharmaceutical Industries CEO Kåre Schultz's 2021 pay slips 7% to $15M

Teva Pharmaceutical Industries reports 2021 executive compensation

By ExecPay News

Published: April 13, 2022

Teva Pharmaceutical Industries reported fiscal year 2021 executive compensation information on April 13, 2022.

In 2021, five executives at Teva Pharmaceutical Industries received on average a compensation package of $5.9M, a 7% decrease compared to previous year.

Average pay of disclosed executives at Teva Pharmaceutical Industries

Kåre Schultz, Chief Executive Officer, received $15M in total, which decreased by 7% compared to 2020. 68% of Schultz's compensation, or $10M, was in stock awards. Schultz also received $2M in non-equity incentive plan, $2M in salary, as well as $652K in other compensation.

Sven Dethlefs, Executive Vice President, North America Commercial, received a compensation package of $3.8M. 55% of the compensation package, or $2.1M, was in stock awards.

Eric Drap, Executive Vice President, Global Operations, earned $3.8M in 2021, a 1% decrease compared to previous year.

Mark Sabag, Executive Vice President, International Markets Commercial, received $3.8M in 2021.

Eli Kalif, Chief Financial Officer, earned $3.5M in 2021, a 5% decrease compared to previous year.